DOZA supplies BPC-157 in pre-mixed pen format manufactured by Pen Peptide: 5 mg (200 clicks, 1 click = 25 mcg) in stabilized MSSPT (Molecular Structure Stabilization Process Technology) form
Your clinician may recommend general wellness guidance such as staying hydrated and listening to your body after treatment
These diverse applications position Epithalon as a promising compound in age-related health and regenerative medicine studies
Clinical Background BPC-157 was introduced in 1993 and initially studied as a potential treatment for inflammatory bowel disease due to its anti-ulcer effects

Comparison CompoundClassPathway / targetResearch focusFormat SemaxACTH-fragment peptideBDNF / NGF signallingNeurotrophic & cognitive researchVial SelankAnxiolytic peptide (Tuftsin analogue)GABA-BDNF interplayNeuropeptide / anxiolytic-model researchVial Semax + SelankPeptide blendCombined BDNF/NGF & GABA pathwaysComparative neuropeptide researchVial CerebrolysinMulti-peptide preparationNeurotrophic factor signallingNeurotrophic-pathway researchVial P21 (P021)Neurotrophic peptideTrkB receptorBDNF-mimetic signalling researchVial DihexaPeptidomimetic (small molecule)HGF / c-Met pathwaySynaptogenesis researchCapsules J-147Small moleculeMitochondrial / neurotrophic signallingNeuroprotective-model researchCapsules 9-Me-BCSmall molecule (beta-carboline)GDNF / dopaminergic pathwayNeurotrophic-model researchCapsules Methylene BlueSmall molecule (phenothiazine)Mitochondrial electron transport chainOxidative-stress & metabolism researchCapsules DSIPSleep-regulatory peptideDelta-wave / neuroendocrine axisSleep-signalling researchVial Every compound in this category is supplied as Research Use Only material with: Peer-reviewed literature underpinning this category

Libby CJ, Zhang S, Benavides GA, Scott SE, Li Y, Redmann M, et al